Agenda Topics- Academia - Industry Collaborative Initiatives
- Academic & Not-for-Profit Screening Operations
- Future of Big Pharma Discovery Platforms
- Novel and Enabling Screening Technologies in 2012
- RNAi Technologies 2012
- Should Academia be doing Drug Discovery
- Showcasing your Screening Lab: Capability & Capacity
- Vendor/User Perspectives on HCA in 2012
Sponsorship and Exhibition OpportunitiesAaron Woodley, Sales & Marketing Manager a.woodley@selectbiosciences.com +44 (0)1787 315129
|
SpeakersRicardo Macarron, Vice President, GlaxoSmithKline Larry Sklar, Director, University of New Mexico Health Sciences Center John Watson, Director, Promega Paul Johnston, Research Associate Professor, University of Pittsburgh Christophe Antczak, Assistant Director, Memorial Sloan Kettering Cancer Center Haian Fu, Professor & Director, Emory University Terry Riss, Senior Project Manager, Promega Rathnam Chaguturu, Senior Director, SRI International Michael Walters, Director of Combinatorial Chemistry Laboratory, University of Minnesota Thomas Chung, Director of Outreach/Project Manager, Sanford Burnham Medical Research Institute Peter Brown, Group Leader, University of Toronto Robert Zivin, Research Associate Professor, University of Miami Christopher Austin, Director, National Institutes of Health Bahne Stechmann, Scientific Manager, Leibniz-Institut für Molekulare Pharmakologie Mohan Thiruvazhi, Director, GVK Bio John Hayley, Senior Director, EMT, Biology, OSI Pharmaceuticals
|